QuidelOrtho Corporation (QDEL)
After hours:
| Previous close | 42.74 |
| Open | 42.46 |
| Bid | 42.04 x 100 |
| Ask | 42.18 x 100 |
| Day's range | 41.84 - 42.79 |
| 52-week range | 29.74 - 75.86 |
| Volume | |
| Avg. volume | 1,058,943 |
| Market cap | 2.822B |
| Beta (5Y monthly) | 0.09 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -27.75 |
| Earnings date | 31 July 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 56.17 |
Simply Wall St.QuidelOrtho Insider Ups Holding By 54% During Year
Looking at QuidelOrtho Corporation's ( NASDAQ:QDEL ) insider transactions over the last year, we can see that insiders...
Business WireQuidelOrtho Announces New R&D Executive Leader
SAN DIEGO, October 09, 2024--QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in innovative diagnostic solutions, is pleased to announce the appointment of Jonathan Siegrist, PhD, as its new Executive Vice President of Research and Development (R&D) and Chief Technology Officer (CTO), effective as of October 7, 2024.
Business WireQuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer
SAN DIEGO, September 10, 2024--QuidelOrtho Corporation (Nasdaq: QDEL) is pleased to announce the appointment of Lee Bowman as Chief Human Resources Officer (CHRO). In this pivotal role, Bowman leads QuidelOrtho’s human resources strategy, driving initiatives that bolster a dynamic and inclusive workplace culture. Bowman reports to Brian Blaser, President and Chief Executive Officer.
